These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
306 related items for PubMed ID: 16492701
1. The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism. McCartney CR, Prendergast KA, Chhabra S, Eagleson CA, Yoo R, Chang RJ, Foster CM, Marshall JC. J Clin Endocrinol Metab; 2006 May; 91(5):1714-22. PubMed ID: 16492701 [Abstract] [Full Text] [Related]
3. Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls. McCartney CR, Blank SK, Prendergast KA, Chhabra S, Eagleson CA, Helm KD, Yoo R, Chang RJ, Foster CM, Caprio S, Marshall JC. J Clin Endocrinol Metab; 2007 Feb; 92(2):430-6. PubMed ID: 17118995 [Abstract] [Full Text] [Related]
4. Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy. El-Khayat HA, Abd El-Basset FZ, Tomoum HY, Tohamy SM, Zaky AA, Mohamed MS, Hakky SM, El Barbary NS, Nassef NM. Epilepsia; 2004 Sep; 45(9):1106-15. PubMed ID: 15329076 [Abstract] [Full Text] [Related]
5. Serum sex hormone-binding globulin levels in healthy children and girls with precocious puberty before and during gonadotropin-releasing hormone agonist treatment. Sørensen K, Andersson AM, Skakkebaek NE, Juul A. J Clin Endocrinol Metab; 2007 Aug; 92(8):3189-96. PubMed ID: 17519314 [Abstract] [Full Text] [Related]
6. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. Vermeulen A, Kaufman JM, Giagulli VA. J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841 [Abstract] [Full Text] [Related]
7. Corticotropin-releasing hormone: a potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche. Ibáñez L, Potau N, Marcos MV, de Zegher F. J Clin Endocrinol Metab; 1999 Dec; 84(12):4602-6. PubMed ID: 10599726 [Abstract] [Full Text] [Related]
8. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. Apter D, Bützow T, Laughlin GA, Yen SS. J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882 [Abstract] [Full Text] [Related]
9. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome. Kazerooni T, Dehghan-Kooshkghazi M. Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019 [Abstract] [Full Text] [Related]
10. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS. Cupisti S, Dittrich R, Binder H, Kajaia N, Hoffmann I, Maltaris T, Beckmann MW, Mueller A. Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884 [Abstract] [Full Text] [Related]
11. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels. Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G. Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364 [Abstract] [Full Text] [Related]
12. Leuprolide acetate-stimulated androgen response during female puberty. Hernandez MI, Martinez-Aguayo A, Cavada G, Avila A, Iñiguez G, Mericq V. Clin Endocrinol (Oxf); 2015 Aug; 83(2):205-11. PubMed ID: 25491105 [Abstract] [Full Text] [Related]
13. Maturation of luteinizing hormone (gonadotropin-releasing hormone) secretion across puberty: evidence for altered regulation in obese peripubertal girls. McCartney CR, Prendergast KA, Blank SK, Helm KD, Chhabra S, Marshall JC. J Clin Endocrinol Metab; 2009 Jan; 94(1):56-66. PubMed ID: 18957503 [Abstract] [Full Text] [Related]
14. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. Coviello AD, Legro RS, Dunaif A. J Clin Endocrinol Metab; 2006 Feb; 91(2):492-7. PubMed ID: 16249280 [Abstract] [Full Text] [Related]
15. Focus on BMI and subclinical hypothyroidism in adolescent girls first examined for amenorrhea or oligomenorrhea. The emerging role of polycystic ovary syndrome. Nezi M, Christopoulos P, Paltoglou G, Gryparis A, Bakoulas V, Deligeoroglou E, Creatsas G, Mastorakos G. J Pediatr Endocrinol Metab; 2016 Jun 01; 29(6):693-702. PubMed ID: 27089404 [Abstract] [Full Text] [Related]
16. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome]. Ságodi L, Lombay B, Vámosi I, Barkai L. Orv Hetil; 2013 Aug 04; 154(31):1226-34. PubMed ID: 23895991 [Abstract] [Full Text] [Related]
18. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome. Thierry van Dessel HJ, Lee PD, Faessen G, Fauser BC, Giudice LC. J Clin Endocrinol Metab; 1999 Sep 01; 84(9):3030-5. PubMed ID: 10487660 [Abstract] [Full Text] [Related]
19. The role of LCPUFA-ω3 on the obesity-associated hyperandrogenemia of pubertal girls: secondary analysis of a randomized clinical trial. López-Alarcón MG, Vital-Reyes VS, Hernández-Hernández FI, Maldonado-Hernández J. J Pediatr Endocrinol Metab; 2020 Mar 26; 33(3):347-354. PubMed ID: 32069236 [Abstract] [Full Text] [Related]
20. Adiposity, chronic inflammation, and the prepubertal decline of sex hormone binding globulin in children: evidence for associations with the timing of puberty (Earlybird 58). Pinkney J, Streeter A, Hosking J, Mostazir M, Jeffery A, Wilkin T. J Clin Endocrinol Metab; 2014 Sep 26; 99(9):3224-32. PubMed ID: 24926948 [Abstract] [Full Text] [Related] Page: [Next] [New Search]